IP Library Granted Patent US 9,909,174
Granted Patent B2
US 9,909,174 · App. 15/214,737 · Granted Mar 6, 2018

Methods and compositions for incorporating nucleotides

Inventors: Steven Gordon (Weston, MA); Jerzy Olejnik (Brookline, MA)
Assignee: Intelligent Bio-Systems, Inc.
C12Q1/6869C12Q1/6874G01N21/05G01N21/645G01N21/6428C12Q2535/101G01N2021/0346G01N2021/058G01N2021/6417G01N2021/6419G01N2021/6421G01N2021/6439G01N2021/6441G01N2021/6471G01N2201/062G01N2201/0627G01N2201/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,909,174
App. No.
15/214,737
Granted
Mar 6, 2018
Kind
B2
Abstract

The invention provides methods and compositions, including, without limitation, algorithms, computer readable media, computer programs, apparatus, and systems for determining the identity of nucleic acids in nucleotide sequences using, for example, data obtained from sequencing by synthesis methods. The methods of the invention include correcting one or more phenomena that are encountered during nucleotide sequencing, such as using sequencing by synthesis methods. These phenomena include, without limitation, sequence lead, sequence lag, spectral crosstalk, and noise resulting from variations in illumination and/or filter responses.

Claims (6)

1. A method for determining an identity of a nucleotide at a position, comprising: a) providing a device configured for measuring color in more than one detector channel, nucleic acid, polymerase, and a mixture of labeled and non-labeled reversible terminators, said labeled reversible terminators comprising a label linked to a nucleotide analogue, said label producing color; b) incorporating, with said polymerase, a first nucleotide analogue from said mixture into said nucleic acid at a position; c) detecting the label of said incorporated first nucleotide analogue in two channels with said device; and d) determining the identity of the incorporated nucleotide at said position.

2. The method of claim 1 , wherein said mixture of labeled and non-labeled reversible terminators is reversibly terminated by an azidomethyl group at the 3′ position.

3. The method of claim 1 , wherein said labeled reversible terminators are labeled with at least one type of fluorescent dye and said detecting of step c) comprising detecting color of said at least one type of fluorescent dye in two channels.

4. The method of claim 3 , wherein said at least one type of fluorescent dye is visible in the yellow channel and the green channel.

5. The method of claim 3 , wherein said at least one type of fluorescent dye is visible in the red channel and the green channel.

6. The method of claim 1 , wherein said nucleic acid comprises primer hybridized to template.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Mar 24, 2023
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: ISOPLEXIS CORPORATION
Reel/Frame 063235/0942 →
PATENT PURCHASE AGREEMENT Recorded Jul 30, 2021
From: QIAGEN SCIENCES, LLC
To: ISOPLEXIS CORPORATION
Reel/Frame 057043/0629 →
SECURITY AGREEMENT Recorded May 28, 2021
From: ISOPLEXIS CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS III, LP
Reel/Frame 056421/0929 →
MERGER Recorded Nov 8, 2018
From: QIAGEN WALTHAM, INC.
To: QIAGEN SCIENCES, LLC
Reel/Frame 047923/0815 →
CHANGE OF NAME Recorded May 17, 2018
From: INTELLIGENT BIO-SYSTEMS, INC.
To: QIAGEN WALTHAM, INC.
Reel/Frame 047132/0861 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 11, 2016
From: GORDON, STEVEN; OLEJNIK, JERZY
To: INTELLIGENT BIO-SYSTEMS, INC.
Reel/Frame 039984/0927 →
Continuity (5)
Continuation 14691042 · Apr 20, 2015
Continuation 13305415 · Nov 28, 2011
Continuation 12405779 · Mar 17, 2009
Provisional Application 61037845 · Mar 19, 2008
Related Publication 20170029884A1 · Feb 2, 2017